Jul 21st, 2025

Activist Investors Target Drug Developers

Elizabeth Gonzalez-Sussman, Partner, Shareholder Engagement and Activism; Mergers and Acquisitions at Skadden, Arps, Slate, Meagher & Flom, discusses activist investors' move to access $30 billion tied up in biotech stocks. She speaks with Scarlet Fu and Crystal Tse on "Bloomberg Markets."

Top Video

Explore More

Duration:2:19

Musk Wants to Get SpaceX IPO Underway 'Pretty Soon'

Duration:2:26

Chinese Economy 'Resilient' Despite Slowdown, HSBC Says

Duration:2:12

CDC to Get Some Americans Out of Ebola Region in Congo

The Opening Trade

Duration:2:17

US Says China to Buy $17 Billion in Farm Goods Annually

Duration:5:21

What to Expect From Nvidia Earnings This Week

Duration:8:14

Polls Open Tuesday as Six States Vote on 'Mini' Super Tuesday

Duration:8:37

US Gasoline Prices Near Record High

Duration:3:35

Lescure Says Bond Markets Indicating 'High Uncertainty'

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.